Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory myopathies

C V Oddis1, T A Medsger

  • 1Department of Medicine, University of Pittsburgh School of Medicine, PA 15261, USA.

Bailliere'S Clinical Rheumatology
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Recent advances in myositis autoantibodies, muscle biopsy analysis, and immunogenetics enhance understanding of inflammatory myopathies. New clinical and lab data necessitate revising current classification and diagnostic criteria.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.

Scandinavian journal of rheumatology·2019
Same author

There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Scandinavian journal of rheumatology·2017
Same author

Update on the pharmacological treatment of adult myositis.

Journal of internal medicine·2016
Same author

Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients.

Clinical and experimental rheumatology·2014
Same author

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.

Arthritis and rheumatism·2009
Same author

Sensory Neuropathy With Sjögren's Syndrome, Thymoma, and Hypogammaglobulinemia.

Journal of clinical neuromuscular disease·2008
Same journal

Regional soft tissue pains: alias myofascial pain?

Bailliere's clinical rheumatology·1999
Same journal

The knee

Bailliere's clinical rheumatology·1999
Same journal

The elbow, forearm, wrist and hand

Bailliere's clinical rheumatology·1999
Same journal

Shoulder disorders: a state-of-the-art review

Bailliere's clinical rheumatology·1999
Same journal

The neck

Bailliere's clinical rheumatology·1999
Same journal

Treatment options for regional musculoskeletal pain: what is the evidence?

Bailliere's clinical rheumatology·1999
See all related articles

Area of Science:

  • Rheumatology
  • Neurology
  • Immunology

Background:

  • Understanding of inflammatory myopathies has significantly advanced due to new insights into myositis-specific autoantibodies.
  • Histopathologic analysis of muscle biopsies and immunogenetic features of serologic subsets have improved our comprehension of disease pathogenesis.
  • Expanded clinical descriptions of specific conditions like inclusion body myositis and amyopathic dermatomyositis highlight progress in patient evaluation.

Purpose of the Study:

  • To review recent advancements in the understanding and evaluation of inflammatory myopathies.
  • To discuss the impact of new autoantibody discoveries, histopathology, and immunogenetics on myositis research.
  • To highlight the role of emerging techniques in assessing disease activity and the need for updated diagnostic criteria.

Related Experiment Videos

Main Methods:

  • Review of recent scientific literature on myositis.
  • Analysis of new autoantibody profiles and their association with disease subsets.
  • Evaluation of histopathologic findings from muscle biopsies.
  • Assessment of immunogenetic features.
  • Incorporation of data from newer techniques like cytokine analysis and magnetic resonance imaging (MRI).

Main Results:

  • New information on myositis autoantibodies, muscle biopsy analysis, and immunogenetics has deepened the understanding of inflammatory myopathies' pathogenesis.
  • Clinical descriptions have expanded, improving the evaluation of patients with myopathy.
  • Emerging techniques like cytokine analysis and MRI offer new avenues for assessing disease activity.

Conclusions:

  • The combination of recent clinical and laboratory findings necessitates a re-evaluation of existing classification and diagnostic criteria for inflammatory myopathies.
  • Continued research integrating autoantibody profiles, histopathology, immunogenetics, and novel assessment tools is crucial.
  • Updated criteria are essential for accurate diagnosis and effective management of patients with myositis.